Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 274,000 | 258,000 | 248,000 | 249,000 | 266,000 |
| Cost of Goods | 33,000 | 21,000 | 25,000 | 24,000 | 24,000 |
| Gross Profit | 241,000 | 237,000 | 223,000 | 225,000 | 242,000 |
| Operating Expenses | 144,000 | 136,000 | 185,000 | 147,000 | 127,000 |
| Operating Income | 97,000 | 101,000 | 38,000 | 78,000 | 115,000 |
| Interest Expense | 11,000 | 15,000 | 13,000 | 16,000 | 19,000 |
| Pre-tax Income | 86,000 | 86,000 | 25,000 | 62,000 | 96,000 |
| Income Tax | 29,000 | 36,000 | -12,000 | 14,000 | 30,000 |
| Net Income Continuous | 57,000 | 50,000 | 37,000 | 48,000 | 66,000 |
| Net Income | $57,000 | $50,000 | $37,000 | $48,000 | $66,000 |
| EPS Basic Total Ops | 0.40 | 0.35 | 0.25 | 0.35 | 0.45 |
| EPS Basic Continuous Ops | 0.40 | 0.35 | 0.26 | 0.33 | 0.46 |
| EPS Diluted Total Ops | 0.40 | 0.35 | 0.20 | 0.35 | 0.45 |
| EPS Diluted Continuous Ops | 0.38 | 0.34 | 0.25 | 0.33 | 0.45 |
| EBITDA(a) | $103,000 | $107,000 | $52,000 | $84,000 | $121,000 |